Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry

Cytometry

Volumn 31, Issue 1, 1998, Pages 37-44

  Dessus Babus, S ^a   Belloc, F ^b   Bebear C M ^a   Poutiers, F ^a   Lacombe, F ^b   Bebear C ^a   De Barbeyrac, B ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Antibiotics; Bacteria; Chlamydia trachomatis; Flow cytometry; In vitro susceptibility

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; ERYTHROMYCIN; OFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FLOW CYTOMETRY; FLUORESCENCE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION;

EID: 0031976024     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980101)31:1<37::AID-CYTO5>3.0.CO;2-G     Document Type: Article

References (38)

1. Bean B, Check IJ, Thomson RB: Practical method for fluconazole susceptibility testing of Candida spp by flow cytometry [abstract F-72]. ASM 96th General Meeting, New Orleans, 1996.
2. Bianchi A, Scieux C, Robache S, Vassias I, Perol Y: Etude comparative des concentrations minimales inhibitrices (CMI) et des concentrations minimales léthales (CML) de la tétracycline, de la minocycline, de l'érythromycine et de la rokitamycine sur onze souches de Chlamydia trachomatis. Pathol Biol 39:442-445, 1991.
3. Bownds SE, Kurzynski TA, Norden MA, Dufek JL, Schell RF: Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J Clin Microbiol 34:1386-1390, 1996.
4. Boye E, Steen HB, Skarstad K: Flow cytometry of bacteria: A promising tool in experimental and clinical microbiology. J Gen Microbiol 129:973-980, 1983.
5. Dailloux M, Villemain P: Activités bactériostatiques et bactéricides des cyclines, macrolides et fluoroquinolones sur Chlamydia trachomatis. Pathol Biol 40:455-460, 1992
6. Dailloux M, Kohler Ch, Laurain C, Le Faou A, Grignon G: Observations en microscopie électronique de l'action de l'érythromycine, doxycycline et ofloxacine sur le cycle de multiplication de Chlamydia trachomatis. Pathol Biol 42:399-405, 1994.
7. Dutilh B, de Barbeyrac B, Lafferrière C, Bébéar C: Activitć comparée in vitro d'un nouveau macrolide RU 28965 et de l'érythromycine vis à vis de Chlamydia trachomatis. Pathol Biol 34:445-447, 1986.
8. Gant VA, Warnes G, Phillips I, Savidge GF: The application of flow cytometry to the study of bacterial responses to antibiotics. J Med Microbiol 39:147-154, 1993.
9. Green L, Petersen B, Steimel L, Haeber P, Current W: Rapid determination of antifungal activity by flow cytometry. J Clin Microbiol 32:1088-1091, 1994.
10. Hooton TM, Batteiger BE, Judson FN, Spruance SL, Stamm WE: Ofloxacin vs. doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother 36:1144-1146, 1992.
11. Jones RB, Van Der Pol B, Martin DH, Shepard MK: Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis 162:1309-1315, 1990.
12. Kelly DJ, Salata KF, Strickman D, Hershey JN: Rickettsia tsutsugamushi infection in cell culture: Antibiotic susceptibility determined by flow cytometry. Am J Trop Med Hygiene 53:602-606, 1995.
13. Kimura M, Kishimoto T, Niki Y, Soejima R: In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents. Antimicrob Agents Chemother 37:801-803, 1993.
14. Kirk SM, Callister SM, Lim LCL, Schell RF: Rapid susceptibility testing of Candida albicans by flow cytometry. J Clin Microbiol 35:358-363, 1997.
15. Levitt D, Zable B, Bard J: Binding, ingestion and growth of Chlamydia trachomatis (L2 Serovar) analyzed by flow cytometry. Cytometry 7:378-383, 1986.
16. Mason DJ, Gant VA: The application of flow cytometry to the estimation of bacterial antibiotic susceptibility. J Antimicrob Chemother 36:441-448, 1995.
17. Mason DJ, Allman R, Stark JM, Lloyd D: Rapid estimation of bacterial susceptibility with flow cytometry. J Microsc 176:8-16, 1994.
18. Monson TA, Schrader JA, Lim CL, Kirk SM, Norden MA, Kurzynski TA, Schell F: Rapid susceptibility test for Legionella pneumophila by using flow cytometry [abstract C-348]. ASM 95th General Meeting, Washington, 1995.
19. Mourad A, Sweet RL, Sugg N, Schachter J: Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother 18:696-698, 1980.
20. Nakata K, Maeda H, Fujii A, Arakawa S, Umezu K, Kamidono S: In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis. Antimicrob Agents Chemother 36:188-190, 1992.
21. Neyts J, Snoeck R, Schols D, Himpens B, De Clercq E: Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anticytomegalovirus agents. J Virol Methods 35:27-38, 1991.
22. Norden MA, Kurzynski TA, Bownds SE, Callister SM, Schell RF: Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol 33:1231-1237, 1995.
23. Ordonez JV, Wehman NM: Rapid flow cytometric antibiotic susceptibility assay for Staphylococcus aureus. Cytometry 14:811-818, 1993.
24. Peeling RW: Standardization of antimicrobial susceptibility testing for Chlamydia trachomatis. In: Chlamydial Infections: Proc. 8th Int. Symp. Human Chlamydial Infections, Orfila J, Byrne GI, Chernesky MA, Grayston JT, Jones RB, Ridgway GL, et al. (eds). Societa Editrice Esculapio Press, Bologna, 1994, pp 346-349.
25. Pore RS: Antibiotic susceptibility testing of Candida albicans by flow cytometry. Curr Microbiol 20:323-328, 1990.
26. Pore RS: Antibiotic susceptibility testing by flow cytometry. J Antimicrob Chemother 34:613-627, 1994.
27. Poutiers F, de Barbeyrac B, Garcia-Macé J, Bébéar C: Activité in vitro d'une nouvelle quinolone, le NM 394, vis à vis de Chlamydia trachomatis. Pathol Biol 44:351-354, 1996.
28. Ridgway GL: Advances in the antimicrobial therapy of chlamydial genital infections. J Infect 25:51-59, 1992.
29. Ridgway GL: Management of chlamydial genital infections: Problems and controversies. In: Proceedings of the Third Meeting of the European Society for Chlamydia Research, Stary A (ed). Societa Editrice Esculapio Press, Bologna, 1996, pp 445-446.
30. Rodriguez P, Vekris A, de Barbeyrac B, Dutilh B, Bonnet J, Bébéar C: Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene. J Clin Microbiol 29:1132-1136, 1991.
31. Snoeck R, Schols D, Andrei G, Neyts J, De Clercq E: Antiviral activity of anti cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique. Antiviral Res 16:1-9, 1991.
32. Steele-Mortimer OA, Meier-Ewert H, Löser R, Hasmann MJ: Flow cytometric analysis of virus-infected cells and its potential use for screening antiviral agents. J Virol Methods 27:241-252, 1990.
33. Strickman D, Sheer T, Salata K, Hershey J, Dasch G, Kelly D, Kuschner R: In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. Antimicrob Agents Chemother 39:2406-2410, 1995.
34. Taylor-Robinson D: Genital chlamydial infections: Clinical aspects, diagnosis, treatment and prevention. In: Recent Advances in Sexually Transmitted Diseases and AIDS, Harris JRW, Forster SM (eds). Churchill Livingstone, London, 1991, pp 219-262.
35. Toomey KE, Barnes RC: Treatment of Chlamydia trachomatis genital infection. Rev Infect Dis 12:S645-S655, 1990.
36. Waldman FM, Hadley WK, Fulwyler MJ, Schachter J: Flow cytometric analysis of Chlamydia trachomatis interaction with L cells. Cytometry 8:55-59, 1987.
37. Welsh LE, Gaydos CA, Quinn TC: In vitro evaluation of activities of azithromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother 36:291-294, 1992.
38. Wenisch C, Linnau KF, Parschalk B, Zedtwitz-Liebenstein K, Georgopoulos A: Rapid susceptibility testing of fungi by flow cytometry using vital staining. J Clin Microbiol 35:5-10, 1997.